Evommune Inc (EVMN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 0 | 0 | 0 | 10,000 | 0 |
| Gross Profit | N/A | N/A | N/A | 10,000 | N/A |
| Operating Expenses | 34,895 | 23,954 | 29,717 | 23,328 | 22,994 |
| Operating Income | -34,895 | -23,954 | -29,717 | -13,328 | -22,994 |
| Other Income | 2,649 | 2,280 | 1,444 | 853 | 9,429 |
| Pre-tax Income | -32,246 | -21,674 | -28,273 | -12,475 | -13,565 |
| Net Income Continuous | -32,246 | -21,674 | -28,273 | -12,475 | -13,565 |
| Net Income | $-32,246 | $-21,674 | $-28,273 | $-12,475 | $-13,565 |
| EPS Basic Total Ops | -0.89 | -0.64 | 15.13 | -8.07 | -8.80 |
| EPS Basic Continuous Ops | -0.89 | -0.64 | 15.14 | -8.07 | -8.80 |
| EPS Diluted Total Ops | -0.89 | -0.64 | 15.13 | -8.07 | -8.80 |
| EPS Diluted Continuous Ops | -0.89 | -0.64 | 15.14 | -8.07 | -8.80 |
| EPS Diluted Before Non-Recurring Items | -0.89 | -0.64 | -1.43 | -8.07 | N/A |
| EBITDA(a) | $-35,099 | $-24,397 | $-29,391 | $-12,344 | $-22,867 |